Hemolytic uremic syndrome with ischemic glomerulonephropathy and obliterative vasculopathy in a systemic sclerosis (SSc) patient treated with cyclosporine-A (CSA). Hemolytic uremic syndrome is not a commonly reported complication in post-transplantation patients treated with CSA, and is extremely rare in SSc patients treated with this drug. Wei-Sheng Chen. Rheumatology International. 21 January 2009. (Also see: Cyclosporine)
This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.
Hemolytic uremic syndrome
No replies to this topic